Danaher Corp
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher Contribution / Headwind from Cepheid Respiratory by Quarter
Contribution / Headwind from Cepheid Respiratory Testing to Total Company Core Sales Growth (%)
Danaher Contribution / Headwind from Cepheid Respiratory: 2.5% in Q3 2026, up 3.0 pts from a year earlier.
Where the Q3 2026 figure comes from
Source: Danaher IR — nongaap_2026Q3 ↗
Reported in Danaher Non-GAAP Reconciliations & Supplemental Data (8-K / IR PDF).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Contribution / Headwind from Cepheid Respiratory Testing to Total Company Core Sales Growth (%) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 2.5% | +3.0 pts | Danaher IR — nongaap_2026Q3 ↗ |
| Q2 2026 | Jun 30, 2026 | 1.5% | +1.0 pts | Danaher IR — nongaap_2026Q3 ↗ |
| Q1 2026 | Mar 31, 2026 | 2.5% | +1.5 pts | Danaher IR — nongaap_2026Q3 ↗ |
| Q4 2025 | Dec 31, 2025 | 1.5% | – | Danaher IR — nongaap_2026Q3 ↗ |
| Q3 2025 | Sep 30, 2025 | -0.5% | – | Danaher IR — nongaap_2026Q3 ↗ |
| Q2 2025 | Jun 30, 2025 | 0.5% | – | Danaher IR — nongaap_2026Q3 ↗ |
| Q1 2025 | Mar 31, 2025 | 1.0% | – | Danaher IR — nongaap_2026Q3 ↗ |
Cite this data
StockData. (2026). Danaher Contribution / Headwind from Cepheid Respiratory (%), quarterly Q1 2025–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/resp-sales-headwind-total
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.